Format
Sort by
Items per page

Send to

Choose Destination

Best matches for diabetes; heart failure; mechanism:

Search results

Items: 1 to 20 of 671

1.

Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.

Kolpakov MA, Sikder K, Sarkar A, Chaki S, Shukla SK, Guo X, Qi Z, Barbery C, Sabri A, Rafiq K.

Cell Physiol Biochem. 2019;53(6):982-998. doi: 10.33594/000000190.

PMID:
31829530
2.

Potassium-lowering agents for the treatment of nonemergent hyperkalemia: pharmacology, dosing and comparative efficacy.

Bridgeman MB, Shah M, Foote E.

Nephrol Dial Transplant. 2019 Dec 1;34(Supplement_3):iii45-iii50. doi: 10.1093/ndt/gfz223.

PMID:
31800078
3.

Adverse Effects of Glycemia-Lowering Medications in Type 2 Diabetes.

Razavi-Nematollahi L, Ismail-Beigi F.

Curr Diab Rep. 2019 Nov 20;19(11):132. doi: 10.1007/s11892-019-1266-7. Review.

PMID:
31748838
4.

Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection: JACC Review Topic of the Week.

Cherney DZ, Odutayo A, Aronson R, Ezekowitz J, Parker JD.

J Am Coll Cardiol. 2019 Nov 19;74(20):2511-2524. doi: 10.1016/j.jacc.2019.09.022. Review.

PMID:
31727290
5.

Predictors affecting anterolateral thigh flap in reconstruction of upper extremity.

Li D, Long F, Lei M.

Medicine (Baltimore). 2019 Nov;98(46):e17884. doi: 10.1097/MD.0000000000017884.

6.

Effect of Empagliflozin on Erythropoietin Levels, Iron Stores and Red Blood Cell Morphology in Patients with Type 2 Diabetes and Coronary Artery Disease.

Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, Jüni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S.

Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044235. [Epub ahead of print]

PMID:
31707794
7.

HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial Fibrillation.

Packer M.

JACC Heart Fail. 2019 Nov 4. pii: S2213-1779(19)30737-1. doi: 10.1016/j.jchf.2019.09.002. [Epub ahead of print] Review.

PMID:
31706838
8.

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.

Li J, Woodward M, Perkovic V, Figtree GA, Heerspink HJL, Mahaffey KW, de Zeeuw D, Vercruysse F, Shaw W, Matthews DR, Neal B.

JACC Heart Fail. 2019 Oct 23. pii: S2213-1779(19)30677-8. doi: 10.1016/j.jchf.2019.08.004. [Epub ahead of print]

9.

Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.

Kaku K, Kisanuki K, Shibata M, Oohira T.

Drug Saf. 2019 Nov;42(11):1311-1327. doi: 10.1007/s40264-019-00857-8. Review.

10.

Thiazolidinediones.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
2018 Jun 6.

11.

Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.

Li H, Fan J, Zhao Y, Zhang X, Dai B, Zhan J, Yin Z, Nie X, Fu XD, Chen C, Wang DW.

Circ Res. 2019 Dec 6;125(12):1106-1120. doi: 10.1161/CIRCRESAHA.119.314898. Epub 2019 Oct 22.

PMID:
31638474
12.

Quantitative proteomic analysis reveals high interference on protein expression of H9c2 cells activated with glucose and cardiotonic steroids.

Meneses-Romero E, Hernández-Orihuela L, Pando-Robles V, López TD, Oses-Prieto JA, Burlingame AL, Batista CVF.

J Proteomics. 2020 Jan 16;211:103536. doi: 10.1016/j.jprot.2019.103536. Epub 2019 Oct 16.

PMID:
31629057
13.

Ketone body metabolism in diabetic and non-diabetic heart failure.

Qian N, Wang Y.

Heart Fail Rev. 2019 Oct 15. doi: 10.1007/s10741-019-09857-3. [Epub ahead of print] Review.

PMID:
31612363
14.

Star-PAP controlled alternative polyadenylation coupled poly(A) tail length regulates protein expression in hypertrophic heart.

Sudheesh AP, Mohan N, Francis N, Laishram RS, Anderson RA.

Nucleic Acids Res. 2019 Nov 18;47(20):10771-10787. doi: 10.1093/nar/gkz875.

15.

Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment.

Liu H, Zhang CH, Ammanamanchi N, Suresh S, Lewarchik C, Rao K, Uys GM, Han L, Abrial M, Yimlamai D, Ganapathy B, Guillermier C, Chen N, Khaladkar M, Spaethling J, Eberwine JH, Kim J, Walsh S, Choudhury S, Little K, Francis K, Sharma M, Viegas M, Bais A, Kostka D, Ding J, Bar-Joseph Z, Wu Y, Yechoor V, Moulik M, Johnson J, Weinberg J, Reyes-Múgica M, Steinhauser ML, Kühn B.

Sci Transl Med. 2019 Oct 9;11(513). pii: eaaw6419. doi: 10.1126/scitranslmed.aaw6419.

PMID:
31597755
17.

Recent Progress on Branched-Chain Amino Acids in Obesity, Diabetes, and Beyond.

Siddik MAB, Shin AC.

Endocrinol Metab (Seoul). 2019 Sep;34(3):234-246. doi: 10.3803/EnM.2019.34.3.234. Review.

18.

Metabolic and Vascular Effect of the Mediterranean Diet.

Tuttolomondo A, Simonetta I, Daidone M, Mogavero A, Ortello A, Pinto A.

Int J Mol Sci. 2019 Sep 23;20(19). pii: E4716. doi: 10.3390/ijms20194716. Review.

19.

Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition.

Wilson JR, Kerman SJ, Hubers SA, Yu C, Nian H, Grouzmann E, Eugster PJ, Mayfield DS, Brown NJ.

J Endocr Soc. 2019 Jul 1;3(10):1784-1798. doi: 10.1210/js.2019-00185. eCollection 2019 Oct 1.

20.

Supplemental Content

Loading ...
Support Center